Trial intelligence / Profile preview

Clinolipid vs Intralipid for Prevention of EFAD in Pediatric Patients

NCT02476994Phase 4Terminated

Sponsor
Baxter
Start
May 2015
Primary completion
Oct 2016
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 4 trial of soybean oil emulsion in essential fatty acid deficiency (EFAD), sponsored by Baxter. Started May 2015; status: terminated.

02

Drugs

soybean oil emulsion
03

Conditions

essential fatty acid deficiency (EFAD)

Beyond the preview

Go deeper on NCT02476994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02476994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call